A study on the effect of continuous intake of test food containing Lactic acid bacteria on vaginal flora.
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000048700
- Lead Sponsor
- IMEQRD Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 80
Not provided
1. Individuals who are diagnosed as bacterial vaginosis in the past 3 months. 2. Individuals who currently are undergoing treatment for any disease, or receive medical treatment such as medical drugs or traditional Chinese medicines. Medications used as needed except antibiotics are acceptable. 3. Individuals whose menstrual cycles are unstable. 4. Individuals who regularly use intestinal regulators involving laxatives. 5. Individuals who received treatments involving oral medicines of antibiotics or Intravenous drip in the past 3 months. 6. Individuals who currently have or past had organic diseases concerning digestive system excluding oral cavity, esophagus, and stomach. 7. Individuals who currently have or past had severe diseases concerning liver, kidney, heart, respiratory system, endocrine, metabolism. 8. Individuals who did vaginal cleansing in the past 3 months. 9. Individuals who use intrauterine contraceptives. 10. Individuals who have currently been taking commercially available drugs, quasi-drug products, foods, or supplements with any functional claims. 11. Individuals who regularly take food mainly compounding lactate acid bacteria involving yogurt or lactic acid bacteria beverage. 12. Individuals who have used public pools containing chlorine, bath, or hot springs in the past 3 months. 13. Individuals who currently have or past had allergies to drugs or foods. 14. Individuals who take more than 60 g alcohol/day. 15. Individuals who are planning to extremely change lifestyle (such as diet, sleep, or exercise) during the study period. 16. Individuals who joined, have been joined, or are planning to join other clinical trials from one month before the trials. 17. Individuals who are currently pregnant or breastfeeding, or planning to pregnant during the study. 18. Individuals who are unsuitable for the study, that judged by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method